Pee Cee Cosma Sope Ltd

Pee Cee Cosma Sope Ltd

₹ 310 1.99%
19 Jun 9:57 a.m.
About

Incorporated in 1986, Pee Cee Cosma Sope
Ltd manufactures Laundry Soap, Detergent
Cake & Powder[1]

Key Points

Business Overview:[1][2]
PCCS is an ISO 9001:2000 certified health hygiene brand which does manufacturing, sale, purchase of detergent cake, cleaning preparation, soap chips, detergent powder and various toiletry and other products, etc. under the Doctor brand

Products & Brands:
a) Laundry Soaps:[3]
Doctor Double Action, Doctor Single Wrapper, Doctor Gre, Doctor Premium, Doctor Shudh, Doctor Super Fine
b) Detergent Powders:[4]
Doctor Advanced, Doctor Ultra, Doctor Washing Powder
c) Detergent Cakes:[5]
Doctor Advanced, Doctor Blue
d) Liquid Soaps:[6]
Doctor Clean

  • Market Cap 82.0 Cr.
  • Current Price 310
  • High / Low 552 / 286
  • Stock P/E 9.83
  • Book Value 212
  • Dividend Yield 0.97 %
  • ROCE 21.1 %
  • ROE 15.9 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Working capital days have increased from 37.4 days to 64.9 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
29.62 36.74 32.57 33.80 30.54 39.85 30.94 34.31 35.48 39.81 32.64 42.02 43.36
27.24 33.07 28.86 29.73 26.64 35.68 27.78 30.08 33.99 36.25 30.75 37.90 40.27
Operating Profit 2.38 3.67 3.71 4.07 3.90 4.17 3.16 4.23 1.49 3.56 1.89 4.12 3.09
OPM % 8.04% 9.99% 11.39% 12.04% 12.77% 10.46% 10.21% 12.33% 4.20% 8.94% 5.79% 9.80% 7.13%
0.13 0.13 0.13 0.13 0.22 0.70 0.82 0.20 0.01 0.88 0.48 0.36 -1.47
Interest 0.20 0.14 0.09 0.05 0.03 0.02 0.05 0.09 0.07 0.02 0.01 0.02 0.03
Depreciation 0.37 0.36 0.40 0.41 0.43 0.33 0.39 0.41 0.51 0.38 0.40 0.42 0.43
Profit before tax 1.94 3.30 3.35 3.74 3.66 4.52 3.54 3.93 0.92 4.04 1.96 4.04 1.16
Tax % 25.26% 26.67% 25.07% 25.13% 25.96% 25.66% 24.58% 24.94% 29.35% 26.24% 25.51% 24.26% 26.72%
1.45 2.43 2.51 2.79 2.71 3.35 2.66 2.94 0.65 2.99 1.46 3.05 0.84
EPS in Rs 5.48 9.18 9.48 10.54 10.24 12.66 10.05 11.11 2.46 11.30 5.52 11.53 3.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
80 75 71 76 76 74 82 93 125 134 141 158
77 70 67 70 71 70 76 90 119 118 128 145
Operating Profit 4 5 3 6 5 3 7 3 5 15 13 13
OPM % 5% 6% 5% 8% 6% 5% 8% 3% 4% 11% 9% 8%
0 0 0 0 0 0 1 1 1 1 2 0
Interest 1 1 0 0 0 0 0 0 1 0 0 0
Depreciation 1 1 1 1 1 1 1 1 2 2 2 2
Profit before tax 2 3 2 6 4 3 6 2 3 14 13 11
Tax % 34% 35% 33% 34% 30% 27% 26% 27% 26% 26% 26% 26%
1 2 2 4 3 2 5 2 2 10 10 8
EPS in Rs 5.10 7.75 5.82 13.87 10.73 7.97 18.03 6.39 9.41 39.45 36.31 31.52
Dividend Payout % 29% 23% 43% 22% 28% 38% 17% 16% 21% 13% 8% 10%
Compounded Sales Growth
10 Years: 8%
5 Years: 14%
3 Years: 8%
TTM: 12%
Compounded Profit Growth
10 Years: 15%
5 Years: 12%
3 Years: 50%
TTM: -4%
Stock Price CAGR
10 Years: 14%
5 Years: 14%
3 Years: 16%
1 Year: -35%
Return on Equity
10 Years: 16%
5 Years: 17%
3 Years: 21%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 12 13 15 18 20 20 25 26 28 38 46 53
8 6 4 3 3 5 3 14 11 2 2 0
6 5 4 4 4 4 5 5 6 6 7 7
Total Liabilities 28 27 26 27 30 32 36 47 47 48 58 64
8 7 10 9 9 9 9 17 18 18 18 17
CWIP -0 0 0 -0 -0 -0 0 2 0 0 0 0
Investments -0 -0 -0 -0 -0 -0 -0 -0 -0 4 9 18
20 19 16 18 21 23 27 28 28 26 30 29
Total Assets 28 27 26 27 30 32 36 47 47 48 58 64

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
5 1 3 2 1 3 0 9 3 10 7 15
-1 -0 -0 -0 -0 -1 -0 -11 -1 -5 -6 -9
-4 -1 -3 -2 -1 -1 -2 3 -4 -5 -1 -2
Net Cash Flow 0 -0 -0 -0 0 2 -2 1 -1 -0 -0 3
Free Cash Flow 4 1 3 2 1 3 -0 -1 2 9 6 14
CFO/OP 151% 55% 108% 64% 50% 115% 26% 335% 82% 91% 81% 139%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 2 2 1 2 2 1 2 2 2 1 2 1
Inventory Days 81 85 67 76 79 65 71 62 58 55 63 51
Days Payable 16 9 8 9 9 10 14 9 5 11 15 10
Cash Conversion Cycle 67 78 61 69 72 56 59 54 55 45 50 41
Working Capital Days 11 16 14 28 38 26 18 3 17 21 27 65
ROCE % 12% 18% 13% 26% 17% 11% 23% 8% 10% 34% 26% 21%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Jul 2025
Total Sales Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
Count
Number of Manufacturing Units
Count
Number of Distributors
Count
Number of Retailers
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.56% 74.21% 74.17% 73.07% 73.07% 72.57% 72.58% 72.58% 72.58% 72.58% 72.58% 72.58%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.78% 0.78% 0.78% 0.78% 0.78%
25.43% 25.80% 25.83% 26.91% 26.92% 27.43% 27.41% 26.64% 26.65% 26.65% 26.64% 26.65%
No. of Shareholders 2,4832,4342,5522,9172,8773,2973,5643,4763,6763,6853,6613,648

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents